As of June 13, 2025, Callitas Health Inc (LILY.CN) reports a ROA (Return on Assets) of 0.62%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Callitas Health Inc's ROA (Return on Assets)
Over recent years, Callitas Health Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2019-12-31 | 0.62% |
| 2018-12-31 | -24008.90% |
| 2017-12-31 | -188.22% |
| 2016-12-31 | -73.65% |
| 2015-12-31 | -868.10% |
This slight downward trend highlights how Callitas Health Inc manages its efficiency in using assets to generate earnings over time.
Comparing Callitas Health Inc's ROA (Return on Assets) to Peers
To better understand Callitas Health Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Callitas Health Inc (LILY.CN) | 0.62% |
| NewBridge Global Ventures Inc (NBGV) | -22.53% |
| Context Therapeutics Inc (CNTX) | -27.24% |
| Fast Line Holding Inc (GFGVF) | -38.42% |
| BiondVax Pharmaceuticals Ltd (BVXV) | -40.01% |
| CTT Pharmaceutical Holdings Inc (CTTH) | -40.43% |
Compared to its competitors, Callitas Health Inc's ROA (Return on Assets) is higher than all peers, demonstrating superior efficiency in generating earnings from assets.